Benoxaprofen showed a promising prednisolone-sparing effect in rheumatoid arthritis patients but was discontinued due to significant skin side effects. Further studies are needed to assess its potential benefits against its risks.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: